scholarly journals CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice

2016 ◽  
Vol 24 (3) ◽  
pp. 564-569 ◽  
Author(s):  
Li Xu ◽  
Ki Ho Park ◽  
Lixia Zhao ◽  
Jing Xu ◽  
Mona El Refaey ◽  
...  
2012 ◽  
Vol 181 (2) ◽  
pp. 392-400 ◽  
Author(s):  
Bo Wu ◽  
Peijuan Lu ◽  
Caryn Cloer ◽  
Mona Shaban ◽  
Snimar Grewal ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Yuan Zhang ◽  
Allan M. Showalter

For the past 5 years, clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) technology has appeared in the molecular biology research spotlight. As a game-changing player in genome editing, CRISPR/Cas9 technology has revolutionized animal research, including medical research and human gene therapy as well as plant science research, particularly for crop improvement. One of the most common applications of CRISPR/Cas9 is to generate genetic knock-out mutants. Recently, several multiplex genome editing approaches utilizing CRISPR/Cas9 were developed and applied in various aspects of plant research. Here we summarize these approaches as they relate to plants, particularly with respect to understanding the biosynthesis and function of the plant cell wall. The plant cell wall is a polysaccharide-rich cell structure that is vital to plant cell formation, growth, and development. Humans are heavily dependent on the byproducts of the plant cell wall such as shelter, food, clothes, and fuel. Genes involved in the assembly of the plant cell wall are often highly redundant. To identify these redundant genes, higher-order knock-out mutants need to be generated, which is conventionally done by genetic crossing. Compared with genetic crossing, CRISPR/Cas9 multi-gene targeting can greatly shorten the process of higher-order mutant generation and screening, which is especially useful to characterize cell wall related genes in plant species that require longer growth time. Moreover, CRISPR/Cas9 makes it possible to knock out genes when null T-DNA mutants are not available or are genetically linked. Because of these advantages, CRISPR/Cas9 is becoming an ideal and indispensable tool to perform functional studies in plant cell wall research. In this review, we provide perspectives on how to design CRISPR/Cas9 to achieve efficient gene editing and multi-gene targeting in plants. We also discuss the recent development of the virus-based CRISPR/Cas9 system and the application of CRISPR/Cas9 to knock in genes. Lastly, we summarized current progress on using CRISPR/Cas9 for the characterization of plant cell wall-related genes.


2019 ◽  
Vol 27 (8) ◽  
pp. 1407-1414 ◽  
Author(s):  
Li Xu ◽  
Yeh Siang Lau ◽  
Yandi Gao ◽  
Haiwen Li ◽  
Renzhi Han
Keyword(s):  

2019 ◽  
Vol 29 ◽  
pp. S160-S161
Author(s):  
P. Mantuano ◽  
A. Mele ◽  
O. Cappellari ◽  
A. Fonzino ◽  
F. Sanarica ◽  
...  
Keyword(s):  
Ex Vivo ◽  
Mdx Mice ◽  

2018 ◽  
Vol 10 (444) ◽  
pp. eaat0195 ◽  
Author(s):  
Xianjun Gao ◽  
Ning Ran ◽  
Xue Dong ◽  
Bingfeng Zuo ◽  
Rong Yang ◽  
...  

Exosomes are circulating nanovesicular carriers of macromolecules, increasingly used for diagnostics and therapeutics. The ability to load and target patient-derived exosomes without altering exosomal surfaces is key to unlocking their therapeutic potential. We demonstrate that a peptide (CP05) identified by phage display enables targeting, cargo loading, and capture of exosomes from diverse origins, including patient-derived exosomes, through binding to CD63—an exosomal surface protein. Systemic administration of exosomes loaded with CP05-modified, dystrophin splice–correcting phosphorodiamidate morpholino oligomer (EXOPMO) increased dystrophin protein 18-fold in quadriceps of dystrophin-deficient mdx mice compared to CP05-PMO. Loading CP05-muscle–targeting peptide on EXOPMO further increased dystrophin expression in muscle with functional improvement without any detectable toxicity. Our study demonstrates that an exosomal anchor peptide enables direct, effective functionalization and capture of exosomes, thus providing a tool for exosome engineering, probing gene function in vivo, and targeted therapeutic drug delivery.


2016 ◽  
Vol 170 (4) ◽  
pp. 1917-1928 ◽  
Author(s):  
Noel J. Sauer ◽  
Javier Narváez-Vásquez ◽  
Jerry Mozoruk ◽  
Ryan B. Miller ◽  
Zachary J. Warburg ◽  
...  

2017 ◽  
Vol 121 (8) ◽  
pp. 923-929 ◽  
Author(s):  
Mona El Refaey ◽  
Li Xu ◽  
Yandi Gao ◽  
Benjamin D. Canan ◽  
T.M. Ayodele Adesanya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document